NPR's Dan Charles reports that a patent used in DNA fingerprinting and throughout the biotech industry is being called into question. A court has ruled that the company that applied for the patent withheld crucial information from the U.S. Patent Office. The ruling could have widespread implications for the biotech industry by allowing competition into an area that has been dominated by the Swiss pharmaceutical firm Hoffmann-LaRoche.
Copyright 1996 NPR
